DIFFERENT HLA DR-DQ ASSOCIATIONS IN SUBGROUPS OF IDIOPATHIC MYASTHENIA-GRAVIS

被引:63
作者
CARLSSON, B
WALLIN, J
PIRSKANEN, R
MATELL, G
SMITH, CIE
机构
[1] SODER SJUKHUSET, DEPT NEUROL, CTR MYASTHENIA GRAVIS, STOCKHOLM, SWEDEN
[2] KAROLINSKA INST, HUDDINGE UNIV HOSP, NOVUM, DEPT CLIN IMMUNOL, S-14152 HUDDINGE, SWEDEN
关键词
D O I
10.1007/BF02115001
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
We have investigated the HLA-DRB and -DQB gene polymorphism in 131 myasthenia gravis (MG) patients. The HLA genotypes in these patients were assigned by means of restriction fragment length polymorphism (RFLP)-defined DR-DQ haplotypes, correlating to serologic HLA class II typing. Using this technique we could, among randomly selected non-thymomatous (NT)-MG patients, confirm the strong association to DR3, and 70% of the patients were found to carry a specific DR3-positive DR-DQ haplotype, T-3.1. Furthermore, an analysis of T-3.1- NT-MG patients revealed that 59 % were T-4.1÷ (DR4, DQw8). Thymic hyperplasia was found in approximately 85 % of the T-3.1+, as well as of the T-4.1+ /3.1- patients. As previously observed, we found a clear dominance of females among the T-3.1+ NT-MG patients. However, among T-4.1+/3.1- patients, males were as common as females. Furthermore, the T-4.1+ patients were significantly older at the onset of disease than those who were T-3.1+. In female MG patients, the DRwl5-Dw2-positive haplotype T-2.1 was strongly correlated with the presence of thymoma (T-MG). These data indicate that the HLA associations in early vs late onset of NT-MG are different, and that female patients with and without thymoma differ from each other with regard to HLA markers. Thus, at least three different HLA DR-DQ associations are found in subgroups of idiopathic MG. © 1990 Springer-Verlag.
引用
收藏
页码:285 / 290
页数:6
相关论文
共 39 条
  • [1] SERUM GLOBULIN IN MYASTHENIA-GRAVIS - INHIBITION OF ALPHA-BUNGAROTOXIN BINDING TO ACETYLCHOLINE RECEPTORS
    ALMON, RR
    ANDREW, CG
    APPEL, SH
    [J]. SCIENCE, 1974, 186 (4158) : 55 - 57
  • [2] BAUR MP, 1984, HISTOCOMPATIBILITY T, P756
  • [3] BELL J, 1986, LANCET, V1, P1058
  • [4] DRAINAGE OF THORACIC-DUCT LYMPH IN 12 PATIENTS WITH MYASTHENIA-GRAVIS
    BERGSTROM, K
    FRANKSSON, C
    MATELL, G
    NILSSON, BY
    PERSSON, A
    REIS, GV
    STENSMAN, R
    [J]. EUROPEAN NEUROLOGY, 1975, 13 (01) : 19 - 30
  • [5] DNA-RFLP ANALYSIS AND GENOTYPING OF HLA-DR AND DQ ANTIGENS
    BIDWELL, J
    [J]. IMMUNOLOGY TODAY, 1988, 9 (01): : 18 - 23
  • [6] BOHME J, 1986, J IMMUNOL, V137, P941
  • [7] INVITRO PROLIFERATIVE RESPONSES AND ANTIBODY-TITERS SPECIFIC TO HUMAN ACETYLCHOLINE-RECEPTOR SYNTHETIC PEPTIDES IN PATIENTS WITH MYASTHENIA-GRAVIS AND RELATION TO HLA CLASS-II GENES
    BROCKE, S
    BRAUTBAR, C
    STEINMAN, L
    ABRAMSKY, O
    ROTHBARD, J
    NEUMANN, D
    FUCHS, S
    MOZES, E
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1988, 82 (06) : 1894 - 1900
  • [8] HLA-DR-DQ HAPLOTYPES DEFINED BY RESTRICTION FRAGMENT ANALYSIS - CORRELATION TO SEROLOGY
    CARLSSON, B
    WALLIN, J
    BOHME, J
    MOLLER, E
    [J]. HUMAN IMMUNOLOGY, 1987, 20 (02) : 95 - 113
  • [9] DNA POLYMORPHISM OF HLA CLASS-I AND CLASS-II REGIONS
    COHEN, D
    PAUL, P
    LEGALL, I
    MARCADET, A
    FONT, MP
    COHENHAGUENAUER, O
    SAYAGH, B
    CANN, H
    LALOUEL, JM
    DAUSSET, J
    [J]. IMMUNOLOGICAL REVIEWS, 1985, 85 : 87 - 105
  • [10] A SYSTEMATIC STUDY OF HLA CLASS-II-BETA DNA RESTRICTION FRAGMENTS IN INSULIN-DEPENDENT DIABETES-MELLITUS
    COHENHAGUENAUER, O
    ROBBINS, E
    MASSART, C
    BUSSON, M
    DESCHAMPS, I
    HORS, J
    LALOUEL, JM
    DAUSSET, J
    COHEN, D
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (10) : 3335 - 3339